Search Results

There are 8272 results for: content related to: A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I

  1. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  2. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  3. You have free access to this content
    Oral direct thrombin inhibitors in clinical development

    Journal of Internal Medicine

    Volume 254, Issue 4, October 2003, Pages: 322–334, D. Gustafsson

    Version of Record online : 15 SEP 2003, DOI: 10.1046/j.1365-2796.2003.01225.x

  4. No Pharmacokinetic or Pharmacodynamic Interaction Between Atorvastatin and the Oral Direct Thrombin Inhibitor Ximelagatran

    The Journal of Clinical Pharmacology

    Volume 44, Issue 8, August 2004, Pages: 928–934, Dr Troy C. Sarich, Dr Kajs-Marie Schützer, Hassan Dorani, Dr Ulrika Wall, Dr Inge Kalies, Lis Ohlsson and Dr Ulf G. Eriksson

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268047

  5. A Pharmacokinetic Study of the Combined Administration of Amiodarone and Ximelagatran, an Oral Direct Thrombin Inhibitor

    The Journal of Clinical Pharmacology

    Volume 44, Issue 9, September 2004, Pages: 1063–1071, Dr. Renli Teng, Dr. Troy C. Sarich, Dr. Ulf G. Eriksson, Ms. Jennifer E. Hamer, Mr. Stephen Gillette, Dr. Kajs-Marie Schützer, Dr. Glenn F. Carlson Jr and Dr. Peter R. Kowey

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268446

  6. A Preliminary Assessment of the Critical Differences Between Novel Oral Anticoagulants Currently in Development

    The Journal of Clinical Pharmacology

    Volume 45, Issue 9, September 2005, Pages: 1004–1017, Brian F. McBride

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005278084

  7. You have free access to this content
    The oral direct thrombin inhibitor, ximelagatran, an alternative for anticoagulant treatment during the puerperium and lactation

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 112, Issue 5, May 2005, Pages: 579–583, M. Hellgren, S. Johansson, U.G. Eriksson and K. Wåhlander

    Version of Record online : 8 DEC 2004, DOI: 10.1111/j.1471-0528.2004.00494.x

  8. The Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor, Are Unaffected by a Single Dose of Alcohol

    The Journal of Clinical Pharmacology

    Volume 44, Issue 4, April 2004, Pages: 388–393, Troy C. Sarich, Susanne Johansson, Kajs-Marie Schützer, Ulrika Wall, Eva Kessler, Renli Teng and Ulf G. Eriksson

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004263649

  9. Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study

    Clinical and Experimental Pharmacology and Physiology

    Volume 38, Issue 11, November 2011, Pages: 783–786, Martin Feuring, Martin Wehling and Armin Schultz

    Version of Record online : 20 OCT 2011, DOI: 10.1111/j.1440-1681.2011.05593.x

  10. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

    Intervention Review

    The Cochrane Library

    Marcello Di Nisio, Ettore Porreca, Matteo Candeloro, Michele De Tursi, Ilaria Russi and Anne WS Rutjes

    Published Online : 1 DEC 2016, DOI: 10.1002/14651858.CD008500.pub4

  11. You have free access to this content
    Bleeding profiles of anticoagulants, including the novel oral direct thrombin inhibitor ximelagatran: definitions, incidence and management

    European Journal of Haematology

    Volume 73, Issue 4, October 2004, Pages: 227–242, David Bergqvist

    Version of Record online : 3 SEP 2004, DOI: 10.1111/j.1600-0609.2004.00298.x

  12. Safety of Outpatient Dalteparin Therapy in Veterans with Mechanical Heart Valves

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 11, November 2005, Pages: 1560–1565, Jessica L. O'Neill, Petra S. Flanagan, Carolyn R. Zaleon and Laurel A. Copeland

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.11.1560

  13. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement

    Intervention Review

    The Cochrane Library

    Carlos A Salazar, German Malaga and Giuliana Malasquez

    Published Online : 14 APR 2010, DOI: 10.1002/14651858.CD005981.pub2

  14. Neue Daten aus klinischen Studien: Niedermolekulare Heparine, Fondaparinux und Melagatran

    Pharmazie in unserer Zeit

    Volume 33, Issue 3, Mai 2004, Pages: 206–218, Rupert M. Bauersachs

    Version of Record online : 7 MAY 2004, DOI: 10.1002/pauz.200400069

  15. You have free access to this content
    Treatment of upper-extremity deep vein thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 10, October 2011, Pages: 1924–1930, S. W. RATHBUN, J. A. STONER and T. L. WHITSETT

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1538-7836.2011.04466.x

  16. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  17. Life-Threatening Hemorrhage After Dalteparin Therapy in a Patient with Impaired Renal Function

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 6, June 2005, Pages: 881–885, Ms. Sabin S. Egger, Dr. Mikael G. Sawatzki, Dr. Jürgen Drewe and Dr. Stephan Krähenbühl

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.6.881

  18. You have free access to this content
    Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 6, June 2015, Pages: 1028–1035, C. W. Francis, C. M. Kessler, S. Z. Goldhaber, M. J. Kovacs, M. Monreal, M. V. Huisman, D. Bergqvist, A. G. Turpie, T. L. Ortel, A. C. Spyropoulos, I. Pabinger and A. K. Kakkar

    Version of Record online : 10 MAY 2015, DOI: 10.1111/jth.12923

  19. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis A feasibility and health economic study in an outpatient setting

    Journal of Internal Medicine

    Volume 240, Issue 6, December 1996, Pages: 395–401, P. LINDMARKER, M. HOLMSTRÖM and Swedish Venous Thrombosis Dalteparin Trial Group

    Version of Record online : 31 OCT 2003, DOI: 10.1046/j.1365-2796.1996.81877000.x

  20. You have free access to this content
    A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 5, May 2012, Pages: 833–839, S. W. RATHBUN, C. E. ASTON and T. L. WHITSETT

    Version of Record online : 2 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04669.x